Study guide
6.3 Titration, Baseline Dosing, and Breakthrough Pain
Certified Hospice and Palliative Nurse CHPN
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Fees, Windows, and Retakes 1.3 Scoring, Test-Day Rules, and Remote Proctoring 1.4 Recertification: HPAR and the Situational Judgment Exercise
2 Chapter 2: Assessment, Goals, and Care Planning
2.1 Goals of Care and Shared Decision Making 2.2 Interdisciplinary Care Planning and Ongoing Evaluation 2.3 Prognostic and Functional Assessment Tools 2.4 Levels of Care and Care-Setting Transitions
3 Chapter 3: Life-Limiting Disease Progression I
3.1 Cancer, Hematologic, and Paraneoplastic Complications 3.2 Heart Failure and Cardiac Disease Progression 3.3 Pulmonary Disease Progression 3.4 Neurologic Disease Progression
4 Chapter 4: Disease Progression II and Imminent Death
4.1 Dementia, Frailty, and Feeding Decisions 4.2 Renal, Hepatic, and Endocrine Trajectories 4.3 Indicators of Imminent Death
5 Chapter 5: Pain Assessment
5.1 Pain Types, Etiology, and Syndromes 5.2 Verbal and Nonverbal Pain Assessment and Scales 5.3 Factors That Influence the Pain Experience
6 Chapter 6: Pharmacologic Pain Management
6.1 Opioid and Non-Opioid Analgesics by Pain Type and Severity 6.2 Adjuvant Analgesics 6.3 Titration, Baseline Dosing, and Breakthrough Pain 6.4 Equianalgesic Conversion and Route Changes
7 Chapter 7: Nonpharmacologic Pain and Opioid Safety
7.1 Nonpharmacologic Pain Interventions 7.2 Complementary and Integrative Pain Therapies 7.3 Opioid Adverse Effects, Neurotoxicity, and Rotation
8 Chapter 8: Neurological, Cardiovascular, and Respiratory Symptoms
8.1 Neurological Symptoms 8.2 Delirium and Terminal Restlessness 8.3 Cardiovascular Symptoms 8.4 Respiratory Symptoms: Dyspnea, Cough, and Secretions
9 Chapter 9: Gastrointestinal, Genitourinary, and Musculoskeletal Symptoms
9.1 Gastrointestinal Symptoms 9.2 Genitourinary Symptoms 9.3 Musculoskeletal Symptoms
10 Chapter 10: Skin, Metabolic, Hematologic, and Psychospiritual Symptoms
10.1 Skin and Mucous Membrane Symptoms 10.2 Nutritional and Metabolic Symptoms 10.3 Immune and Hematologic Symptoms 10.4 Psychosocial, Emotional, and Spiritual Symptom Burden
11 Chapter 11: Advance Care Planning, Benefits, and Safety
11.1 Advance Care Planning and Life-Sustaining Therapies 11.2 Hospice and Palliative Benefits under Medicare, Medicaid, and Private Insurance 11.3 Patient Safety: Environmental, Physical, and Socioemotional
12 Chapter 12: Communication, Culture, and Psychosocial Support
12.1 Communication Techniques, Barriers, and Family Meetings 12.2 Cultural Humility and Spiritual Needs 12.3 Psychosocial Needs and IDG Participation
13 Chapter 13: Caregiver Education and Medication Management
13.1 Medication Management and Controlled Substances 13.2 Caregiver and Family Self-Care 13.3 Teaching End-Stage Disease, Pain, and Symptom Plans 13.4 Caregiver Skills, DME, Supplies, and Services
14 Chapter 14: Grief, Death, and End-of-Life Ethics
14.1 Grief, Loss, and Bereavement 14.2 Support at the Time of Death and Post-Mortem Care 14.3 Ethical Issues Related to End of Life
15 Chapter 15: Medicare Hospice Compliance and National Standards
15.1 Medicare Hospice Benefit and Conditions of Participation 15.2 Hospice Eligibility, Admission, and Recertification 15.3 National Hospice and Palliative Care Standards 15.4 National Consensus Project Clinical Practice Guidelines
16 Chapter 16: Legal, Professional Practice, Quality, and Policy
16.1 Legal Regulations: CMS, HIPAA, and OSHA 16.2 Professional Boundaries and Ethics 16.3 QAPI, Self-Care, and Precepting 16.4 Policy, Delivery, and Reimbursement Trends
6.3 Titration, Baseline Dosing, and Breakthrough Pain
Key Takeaways Explain This Topic AI
Continuous pain needs around-the-clock dosing; incident and breakthrough flares need a short-acting rescue opioid, not another extended-release tablet crushed for speed.
The CHPN-level breakthrough dose is 10–15% of the total 24-hour opioid (some protocols use 10–20%; study 10–15% as the standard).
Reassess near peak: about 60 minutes after oral IR, faster after subcutaneous or intravenous doses; oral q1h versus q4h depends on whether you have already passed peak.
Three or more breakthrough doses in 24 hours means the basal is too low — add yesterday's PRN milligrams into a new around-the-clock total.
Morphine ER 30 mg every 12 hours is a 60 mg TDD, so oral IR rescue is 6–9 mg; never crush ER products.
Last updated: August 2026
6.3 Titration, Baseline Dosing, and Breakthrough Pain
Once the right opioid is chosen (6.1), CHPN items become arithmetic plus timing. Uncontrolled pain on a hospice service is more often underdosed basal , missing rescue , or rescue given before peak , than a need for an exotic drug. This section is how you titrate.
Around-the-clock for continuous pain
If pain is present most of the day, treat it as continuous . Continuous pain needs around-the-clock (ATC) dosing so the plasma level does not crash every afternoon. Extended-release morphine, oxycodone, or hydromorphone every 12 hours (some morphine ER products are every 24 hours) is the usual oral basal. When ER products are unavailable or the patient is in a rapid titration, immediate-release opioid every 4 hours by the clock can serve as the basal, then convert the 24-hour total to an ER regimen once the dose is stable.
End-of-dose failure — pain that returns like clockwork before the next ER dose — is not mysterious breakthrough. It means the basal milligrams or the interval is wrong. Increase the ATC dose or, less often, shorten the interval. Do not keep adding PRN tablets at hour 11 and call the basal adequate.
Do not crush, chew, or open extended-release tablets or capsules unless the specific product is labeled for that manipulation. Crushing ER morphine dumps 12 hours of opioid at once: a burst of sedation and respiratory depression, then a stretch of no coverage. If the patient can no longer swallow ER tablets, change the route (concentrated oral solution, subcutaneous infusion) rather than pulverizing the ER product.
Breakthrough and incident pain: short-acting rescue
Breakthrough pain is a transient flare on top of otherwise controlled basal pain. Incident pain is breakthrough with a trigger: a dressing change, a transfer, coughing on bone mets. Idiopathic breakthrough has no obvious trigger. All three are treated with a short-acting opioid, not with an extra ER tablet and not with acetaminophen when the patient is already at the acetaminophen ceiling.
For predictable incident pain , pre-medicate with oral IR about 60 minutes before the event (or a parenteral dose closer to the event) so the peak coincides with the dressing change.
The 10–15% rule
The standard CHPN-level breakthrough dose is 10–15% of the total 24-hour opioid dose (TDD) . Some protocols and NCCN language use 10–20% ; learn 10–15% as the exam default , and know that 20% sits at the aggressive end of the same idea. Use the same opioid as the basal when possible so you are not converting on the fly at 2 a.m.
Worked example the blueprint expects you to do in under a minute:
- Morphine ER 30 mg every 12 hours
- Basal TDD = 30 × 2 = 60 mg oral morphine / 24 h
- Breakthrough = 10% of 60 = 6 mg , and 15% of 60 = 9 mg
Order morphine IR 6–9 mg (practically 5–10 mg oral solution or tablet, per available strengths) for breakthrough
If the basal is parenteral, the rescue is parenteral. Ten percent of a 24 mg/day subcutaneous morphine infusion is a 2.4 mg subcutaneous bolus (often rounded to a measurable 2–3 mg).
q1h versus q4h: follow the peak, not a superstition
Redosing frequency is about time to peak , not a single sacred interval.
Route of IR opioid Typical time to peak Practical redose window after a dose that has not yet helped
Oral / concentrated oral solution About 60 minutes After peak: many hospice protocols allow oral IR every 1 hour while pain is uncontrolled; q4h is the traditional conservative PRN for already-controlled pain
- Subcutaneous About 20–30 minutes Often every 30 minutes in a crisis, then space out
- Intravenous About 10–15 minutes Often every 15 minutes in a crisis
Transdermal fentanyl 12–24 hours to meaningful effect; 48–72 hours toward steady state Not a breakthrough route; never titrate a patch every few hours
The dangerous pattern is stacking oral IR every 15 minutes because the nurse is thinking in IV time. Three oral doses before the first one has peaked land together an hour later. Conversely, telling a patient in a pain crisis that oral morphine can only be repeated every 4 hours means they sit through three hours after peak with no legal dose. CHPN logic: do not redose before peak; after peak, you may redose if pain remains severe , using the agency protocol (often q1h oral, q15–30 min parenteral).
After three or more breakthroughs in 24 hours, raise the basal
A rescue dose is a probe . If the patient needs three or more effective breakthrough doses in 24 hours, the ATC dose is too low (assuming the pain is opioid-responsive and there is no new acute complication such as fracture or cord compression). Convert PRN usage into the new basal.
Method:
Add scheduled milligrams used in 24 hours to PRN milligrams used in 24 hours. That sum is the new TDD.
Give the new TDD as ATC (usually split every 12 hours for ER products, or as a continuous subcutaneous infusion).
Recalculate rescue as 10–15% of the new TDD .
Continue a bowel regimen; titration is not complete if constipation is ignored.
Worked example, extending the 30 mg q12h case:
- Basal: morphine ER 30 mg q12h = 60 mg
- Rescue used: morphine IR 8 mg four times = 32 mg
- Four rescues is more than three, so the basal is inadequate
- New TDD = 60 + 32 = 92 mg
- Practical new basal: morphine ER 45 mg q12h = 90 mg (closest clean ER split)
- New breakthrough = 10–15% of ~90 mg = 9–14 mg oral IR (practically 10 mg)
If yesterday's PRNs were taken for incident pain only (one dressing change, one transfer) and basal nights are comfortable, you may pre-medicate for the incident rather than inflating the 24-hour basal. The exam still wants you to know the three-rescue rule for uncontrolled background pain.
Rapid titration versus a patch
When pain is a crisis, titrate with IR oral or parenteral doses at peak intervals, total the milligrams that worked, then build the basal. Do not start a fentanyl patch to titrate. Patches are for stable requirements (6.4). Do not crush ER morphine to mimic an IR dose.
Oral IR onset is often 15–30 minutes, with peak near 60 minutes; subcutaneous and intravenous routes are faster and are preferred when the patient cannot swallow or when you need a quicker peak. Once the 24-hour requirement is known, convert IR-only ATC into ER or into a continuous subcutaneous infusion using the same TDD, then keep a 10–15% rescue.
Titration is a loop: ATC covers the day, rescue covers the flare, three-plus rescues rewrite the ATC, new rescue is 10–15% of the new TDD, reassess at peak.